logo
Notch3-Dependent β-Catenin Signaling Mediates EGFR TKI Drug Persistence in EGFR Mutant NSCLC
Preliminary Results of a Phase II Study of Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
MicroRNA-21 Mediates Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer
Intramolecular Dimerization of EGFR Kinase Domain Duplication as a Novel Activation Mechanism
Reduced TGFBR2 Expression in NSCLC Drives IL-17A Dependent Inflammation via γδT Cells
Phase I Trial of CCL21 Gene Modified Dendritic Cells in Lung Cancer Elicits Immune Responses
TUSC2 Enhances Sensitivity to Anti-PD1 in Kras Mutant Syngeneic Mouse Lung Cancer Through NK Cells
CCL21 Combined with PD-1 Blockade Cooperatively Inhibits Tumor Growth in KRAS Murine Model of NSCLC
Investigating of Immunotherapy and Combination Treatments in Ex-Vivo Culture Model of NSCLC
Unmasking the Role of Activated and Exhausted B Cells in Lung Cancer
The Likelihood of Heterogeneity or Additional Mutation to Compromise Targeting of KRAS G12C
Fatty Acid Synthase Is a Therapeutic Target in Mutant KRAS Lung Cancer
Identification and Characterization of Oncogenic SOS1 Mutations in Lung Adenocarcinoma
Utilizing PET Imaging to Study Mitochondrial Respiration and Dynamics in Lung Cancer
TCR Repertoire of Lung Cancer: An Association with Tumor Molecular and Clinicopathological Features
Somatic Genome Changes in Human Non–Small Cell Lung Cancers
Intratumor Heterogeneity Is Associated with Survival of Patients with Stage IA Lung Adenocarcinoma
Immune Checkpoint Protein Expression at Multiple Metastatic Sites of Lung Cancer
Proteogenomic Landscape of Squamous Cell Lung Cancer
miRNA for Early Detection of Lung Cancer: Comparison of Tissue, Sputum and Plasma Signatures
WINTHER – A Study of Therapy Based on Tumor and Normal-Matched Biopsies: The Lung Cancer Experience
Quantitative Proteomic Analysis of Core-Needle Biopsy of Lung Cancer
Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients
Identifying Lung Cancer Pathways Using PathScore
Reagents Based on Notch Ligands as a Novel Type of Immunotherapeutics
Dissecting the Role of PCDH7, an Oncogenic Cell Surface Receptor, in Non–Small Cell Lung Cancer
Identification of miR-34 Synergistic Small Molecule Inhibitor for Therapy Against NSCLC
Repurposing Ceritinib Using Systems Polypharmacology
Effect Sizes of Somatic Mutations in Lung Cancer: Identifying New Targets and Prioritizing Old Ones
Structure-Based Drug Design Targeting a Pro-Metastatic Collagen Lysyl Hydroxylase
Co-Option of the Extracellular Matrix During Lung Cancer Metastasis and Therapeutic Repsonse
Stromal Hedgehog Pathway Activation Suppresses Growth and Metastasis of Lung Adenocarcinoma
A Semi-Quantitative Approach to Biopsy Diagnosis of Large Cell Neuroendocrine Carcinoma of the Lung
Logistics and Results of a Pilot Rapid Tissue Donation Program
3D Spheroid/Organoid Models of Lung Cancer to Study Lung Cancer Pathogenesis and Testing of New Therapeutics
Lung Cancer Screening at Smilow Cancer Hospital and Yale Cancer Center
Validation of the 12-Gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer
Adenoviral Vectors Transduce Alveolar Macrophages in Lung Cancer Models
Genome Engineering to Generate Models of Chromosome Arm-Level Aneuploidies in Lung Cancer
Concurrent Care and Aggressive End-of-Life Lung Cancer Care
Context-Dependent Oncogenic Adaptation in the Genesis of Lung Cancer
Neoepitopes and Immune Contexture in Pulmonary Premalignancy
Genomic Landscape of Atypical Adenomatous Hyperplasia and Their Progression to Lung Adenocarcinomas
Small Cell Lung Cancer and the Recalcitrant Cancer Research Act
Mechanisms of Osimertinib Resistance in EGFR Mutant Lung Cancer
Targeting Residual Disease in Oncogene-Driven NSCLC
Mechanisms of Heterogeneous Targeted Therapy Response in Brain Metastasis
Deciphering Evolution of Targeted Therapy Resistance in EML4-ALK NSCLC.
Changes in Computer Extracted Features of Vessel Tortuosity on CT Scans Post-Treatment in Responders Compared to Non-Responders for Non–Small Cell Lung Cancer on Immunotherapy